Skip to content
← Full study record

NCT00667342 · MORE INFO

Limitations, agreements, and source contact

A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma · Source last updated 2023-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Accrual to this study was stopped early after 4.5 years due to slow accrual of participants. No eligible participants were enrolled on Stratum B. All enrolled participants continue on study and results will be reported when available.
point Of Contact
email
referralinfo@stjude.org
organization
St. Jude Children's Research Hospital
phone
866-278-5833
title
Michael Bishop, MD
Complete source fields
certain Agreement
pi Sponsor Employee
true
limitations And Caveats
description
Accrual to this study was stopped early after 4.5 years due to slow accrual of participants. No eligible participants were enrolled on Stratum B. All enrolled participants continue on study and results will be reported when available.
point Of Contact
email
referralinfo@stjude.org
organization
St. Jude Children's Research Hospital
phone
866-278-5833
title
Michael Bishop, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice